Thank you for subscribing to CAS Insights™.

You can look forward to new opportunities on the topics that are driving scientific progress across the world.

Only CAS combines the birds-eye view of the world's science with deep expertise from hundreds of scientists to reveal the hidden potential ahead.

CAS Insights 的最新消息

Digital R&D
Why are there no FDA approved TBK1 (TANK-binding kinase) inhibitors on the market, despite the key role it plays in the pathophysiology of many diseases.
|Insights Report
Biotechnology
Science and wearable tech go hand in hand to provide athletes with precise, personalized information to improve their performance.
|Article
Emerging Science
通过最近关于猴痘的头条新闻,了解更多关于研究布局、科学概况和目前可用的治疗方法的信息。对科学出版物有更深的理解,才能清晰地洞察这一新兴的新闻报道。
|Article